Jeon et al. found that silencing CDCA8 can inhibit the growth of HCC by restoring the ATF3 tumor suppressor gene and inactivating the carcinogenic AKT/β-catenin signal. This evidence concerns the gene AKT1 and hepatocellular carcinoma.